A carregar...
Monoamine oxidase-B (MAO-B) inhibitors: implications for disease-modification in Parkinson’s disease
There is a substantial amount of evidence from experimental parkinsonian models to show the neuroprotective effects of monoamine oxidase-B (MAOB) inhibitors. They have been studied for their potential disease-modifying effects in Parkinson’s disease (PD) for over 20 years in various clinical trials....
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3847108/ https://ncbi.nlm.nih.gov/pubmed/24011391 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2047-9158-2-19 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|